Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Novel chiral resolution process for high-purity Salbutamol Sulfate offering cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN1622944A details a safer reductive amination route for chroman derivatives, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN1204130C details a novel chiral resolution process for tetrahydrofuran carboxylic acid intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Novel method for CPL-active spiroalkenes via Pd-catalyzed coupling and thermal aromatization ensures high stability and yield for display materials.
Advanced enzymatic resolution process for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Patent CN1305460A reveals a novel resolution process using L-pyroglutamic acid for high-purity tetrahydrocarbazole intermediates, offering significant cost and supply chain advantages.
Patent CN115894496B reveals a green enzymatic route for Ticagrelor intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable supply.
Patent CN101003549B discloses a robust synthesis of planar chiral [2.2]paracyclophane phosphines via cyclopalladium resolution, offering high stability for pharmaceutical intermediates.
Patent CN110527646B reveals a novel Bacillus tropicalis strain for high-purity S-isomer production. Discover cost-effective agrochemical intermediate manufacturing solutions.
Novel enzymatic resolution process ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains globally. This patent offers significant advantages.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Novel chiral resolution route for high-purity tetrahydroisoquinoline intermediates. Cost-effective, scalable process for peptide drug synthesis.
Novel resolution method for cis-chiral intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains.
Patent CN104558033B reveals biocatalytic resolution for high-purity L-glufosinate-ammonium. Significant cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN101333554B reveals enzymatic resolution for D-lactic acid. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN101289417B details an advanced purification process for D-3-thioacetyl-2-methylpropionyl-L-proline, offering superior yield and optical purity for captopril manufacturing.
Patent CN110177790B details a scalable resolution process for diazaspiro[4.5]decane derivatives, offering high enantiomeric excess and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113717178A discloses a scalable method for chiral 7-azabicyclo[2.2.1]heptane intermediates, offering improved purity and cost efficiency for oncology drug manufacturing.